Author Archives: Harvard Law School Forum on Corporate Governance and Financial Regulation

Disclosure of Beneficial Ownership After the Panama Papers

The disclosure of the “Panama Papers”  focused public interest on how elaborate corporate structures and offshore tax havens can be used by politicians, celebrities and other elites to obscure their assets, including concealing their beneficial ownership of companies. Conventional thinking suggests that trust in corporations and markets depend, in large part, on the existence of […]

Click here to read the complete post
Posted in Accounting & Disclosure, International Corporate Governance & Regulation, Securities Regulation | Tagged , , , , , , , , , , , | Comments Off on Disclosure of Beneficial Ownership After the Panama Papers

The Law and Brexit VII

Despite the protestations of some, the direction of travel in UK Government thinking seems to be towards the negotiation of a “hard” Brexit, meaning limited market access for services and goods to the EU single market. Attitudes also appear to be hardening in other EU member states: the Italian Prime Minister warned during the past […]

Click here to read the complete post
Posted in Banking & Financial Institutions, Financial Regulation, International Corporate Governance & Regulation, Practitioner Publications, Securities Regulation | Tagged , , , , , , , , , , , | Comments Off on The Law and Brexit VII

Weekly Roundup: September 30–October 6, 2016

A Unified Theory of Insider Trading Law Posted by Zachary J. Gubler, Arizona State University, on Friday, September 30, 2016 Tags: Debt securities, Disclosure, Exchange Act, Fiduciary duties, Information environment, Inside information, Insider trading, Liability standards, Repurchases, Rule 10b-5, Securities fraud, Securities regulation AML Obligations of Broker-Dealers Posted by Jonathan N. Eisenberg, K&L Gates LLP, […]

Click here to read the complete post
Posted in Weekly Roundup | Tagged | Comments Off on Weekly Roundup: September 30–October 6, 2016

When Do Merger Benefits to Directors Constitute Disabling Conflicts?

As the Delaware Supreme Court narrows the avenues for post-closing challenges to mergers (see our discussions of the implications of the Corwin and Cornerstone decisions here, here, here, and here), we expect that plaintiffs’ lawyers will increasingly seek to base their merger suits on specific allegations of conflicts that may have tainted the oversight of processes […]

Click here to read the complete post
Posted in Boards of Directors, Court Cases, Mergers & Acquisitions, Practitioner Publications | Tagged , , , , , , , , , , , , | Comments Off on When Do Merger Benefits to Directors Constitute Disabling Conflicts?

The Role of Financial Reporting and Transparency in Corporate Governance

In our article, The Role of Financial Reporting and Transparency in Corporate Governance (Economic Policy Review, 2016), we review the recent corporate governance literature that examines the role of financial reporting in resolving agency conflicts among a firm’s managers, directors, and capital providers. We view governance as the set of contracts that help align managers’ […]

Click here to read the complete post
Posted in Academic Research, Accounting & Disclosure, Banking & Financial Institutions, Boards of Directors, Executive Compensation | Tagged , , , , , , , , , , , , | Comments Off on The Role of Financial Reporting and Transparency in Corporate Governance

Supreme Court’s Anticipated Ruling on Insider Trading

In its 2016 fall term, the U.S. Supreme Court will have the opportunity to consider two cases involving securities laws, one of which is already on the calendar for oral argument. The cases concern the “personal benefit” required to establish liability for insider trading and the jurisdictional requirements for class actions under the Securities Act […]

Click here to read the complete post
Posted in Court Cases, Practitioner Publications, Securities Litigation & Enforcement | Tagged , , , , , , , , , , , , | Comments Off on Supreme Court’s Anticipated Ruling on Insider Trading

2016-2017 Annual Benchmark Voting Policy Survey

ISS received 439 responses to this year’s policy survey, from 417 organizations. One hundred and twenty of the respondents were institutional investors, representing 115 organizations, including 73 asset managers or investment managers, 16 mutual funds, 15 government or state-sponsored pension funds, three foundations/endowments, three insurance companies (investment side), two alternative asset managers, and two labor […]

Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, Executive Compensation, International Corporate Governance & Regulation, Practitioner Publications | Tagged , , , , , , , , , , , , , , , , , | Comments Off on 2016-2017 Annual Benchmark Voting Policy Survey

A Review of the STADA Arzneimittel Proxy Contest and the Activism Landscape in Germany

Active Ownership Capital (“AOC”), an activist investment company that takes minority positions in undervalued small to mid-size publicly traded companies in Western Europe and the Nordics, recently won a small, but significant, victory in a proxy battle it waged against STADA Arzneimittel AG (“STADA” or the “Company”), a publicly listed pharmaceutical company based in Germany. […]

Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, International Corporate Governance & Regulation, Mergers & Acquisitions, Practitioner Publications | Tagged , , , , , , , , , , , | Comments Off on A Review of the STADA Arzneimittel Proxy Contest and the Activism Landscape in Germany

The Insignificance of Clear-Day Poison Pills

Does the presence of a poison pill really matter for firm value? There are good reasons to believe that when it comes to pills, what really matters is their availability, and not whether they have been adopted. After all, even a firm that has not adopted a poison pill can quickly adopt one if a […]

Click here to read the complete post
Posted in Academic Research, Comparative Corporate Governance & Regulation, Empirical Research, Institutional Investors, Mergers & Acquisitions | Tagged , , , , , , , , , , , | Comments Off on The Insignificance of Clear-Day Poison Pills

The Investors’ Exchange

On September 2, 2016, the Investors’ Exchange, LLC (IEX) commenced full operations as a registered national securities exchange. After receiving over 400 comment letters during the U.S. Securities and Exchange Commission’s (SEC) review and a spirited debate on equity market structure, the SEC approved IEX’s application to become a national securities exchange on June 17, […]

Click here to read the complete post
Posted in Practitioner Publications, Securities Regulation | Tagged , , , , , , , | Comments Off on The Investors’ Exchange